Events2Join

CVS Health Corporation reports second quarter 2024 results and ...


CVS Health Corporation reports second quarter 2024 results and ...

CVS Health Corporation announces operating results for the three months ended June 30, 2024.

CVS HEALTH CORPORATION REPORTS SECOND QUARTER ...

CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE · Second quarter total revenues increased to $91.2 ...

CVS HEALTH CORPORATION REPORTS SECOND QUARTER ...

The Company revised its full-year 2024 GAAP diluted EPS, Adjusted EPS and cash flow from operations guidance to reflect continued pressure in the Health Care ...

CVS Health Corporation reports third quarter 2024 results

Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior year · Third quarter GAAP diluted EPS of $0.07 and ...

Financial Information - Results Center - CVS Health - Investors

Adjusted operating income increased 17.4% for the three months ended September 30, 2024 compared to the prior year primarily driven by improved purchasing ...

Q2-2024-Earnings-Presentation.pdf - CVS Health

Delivered revenue growth of 2.6% and adjusted EPS of $1.83 in the second quarter of 2024. Lowered 2024 adjusted EPS guidance to $6.40 to $6.65 ...

CVS Health Corporation Reports Second Quarter 2024 Results And ...

CVS Health Corporation Reports Second Quarter 2024 Results And Revises Full-year 2024 Guidance · Operating income decreased 5.8% primarily due to ...

CVS Health - Investors

CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2024 RESULTS · Investor Fact Sheet · Fact Sheet · SEC Filings · Q3 2024 Form 10-QQ2 2024 Form 10-QQ1 2024 Form 10-Q ...

CVS Health Corporation Reports Earnings Results for the Second ...

CVS Health Corporation reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, ...

CVS Health reports mixed Q2 earnings — and Aetna's Brian Kane is ...

The company reported second-quarter sales of $91.23 billion, missing the target of $91.51 billion. Adjusted EPS of $1.83 decreased from $2.21 in ...

CVS Health announces quarterly dividend

WOONSOCKET, R.I., Sept 19, 2024 — CVS Health® (NYSE: CVS ) has announced that its board of directors has approved a quarterly dividend of sixty-six and ...

What You Need To Know Ahead of CVS Earnings Wednesday

CVS Health reports second-quarter earnings ahead of the opening bell Wednesday, after its first-quarter results sent the company's stock to ...

CVS Health Corporation reports second quarter 2024 results and ...

The Company revised its full-year 2024 GAAP diluted EPS, Adjusted EPS and cash flow from operations guidance to reflect continued pressure in ...

CVS Health | Q2 2024 Earnings Call Transcript

Senior Vice President, Investor Relations & Business Development, CVS Health Corp. Good morning, and welcome to the CVS Health second quarter ...

CVS Health to hold second quarter 2024 earnings conference call

WOONSOCKET, R.I., July 8, 2024 — CVS Health (NYSE: CVS ) will hold a conference call with analysts and investors on Wednesday, August 7th, ...

CVS Health : Second Quarter 2024 Q2 2024 Earnings Release

Second quarter total revenues increased to $91.2 billion, up 2.6% compared to the prior year · Second quarter GAAP diluted EPS of $1.41 and ...

CVS Health to hold second quarter 2024 earnings conference call

WOONSOCKET, R.I., July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, ...

CVS Health Corporation Q2 2024 Earnings Summary - Intellectia.AI

- Pharmacy & Consumer Wellness: Revenue increased by 3.7% to $30.6 billion, driven by a surge in prescription volume and favorable pharmacy drug ...

CVS Health to report Q2 2024 results on Wednesday. Here's what to ...

In the second quarter of 2023, the company earned $2.21 per share. It is estimated that June-quarter revenues increased about 3% to $91.51 ...

CVS Health (CVS) earnings Q2 2024 - CNBC

The company expects 2024 adjusted earnings of $6.40 to $6.65 per share, down from previous guidance of at least $7 per share.